LINTHICUM, Md., Nov. 8, 2006 (PRIMEZONE) -- Dialysis Corporation of America (Nasdaq:DCAI) announced the development of a new facility in Delaware County, Ohio, through an affiliation with Riverside Nephrology Associates, a leading nephrology medical group in the greater Columbus area.
President and CEO Stephen Everett commented, "We look forward to the opportunity to be working with this outstanding group of physicians as we expand our dialysis programs to serve the people of Delaware County, Ohio. This new facility will be our fourth in Ohio, and is in line with DCA's overall development strategy for our Midwest market."
The new facility will offer state-of-the-art equipment and technology, be designed with patient comfort in mind, and include 12 treatment stations.
Separately the company announced its purchase of the remaining sixty percent interest in DCA's Bowling Green Ohio center, in which the company had previously maintained a minority forty percent ownership, and which the company manages under contract.
Dialysis Corporation of America currently owns or manages 32 free-standing operating kidney hemodialysis centers in Georgia, Maryland, New Jersey, Ohio, Pennsylvania, South Carolina and Virginia providing patients with a full range of quality in-center and at-home dialysis services, as well as providing in-hospital services. The company has three new centers under development in Georgia, South Carolina, and Ohio.
This release contains forward-looking statements that are subject to risks and uncertainties that could affect the business and prospects of the company and cause actual results and plans to differ materially from those anticipated. Those factors include, but are not limited to, maintaining continued growth and profitability, delays beyond the company's control with respect to future business events, the highly competitive environment in the establishment and operation of dialysis centers, the ability to develop or acquire additional dialysis facilities, whether patient bases of the company's dialysis facilities can mature to provide profitability, the extensive regulation of dialysis operations, government rate determination for Medicare reimbursement, pricing pressure from private payors, and other risks detailed in the company's filings with the SEC, particularly as described in the company's annual report on Form 10-K for the fiscal year ended December 31, 2005. The historical results contained in this press release are not necessarily indicative of future performance of the company.
The company's press releases, corporate profile, corporate governance materials, quarterly and current reports, and other filings with the SEC are available on Dialysis Corporation of America's internet home page: http://www.dialysiscorporation.com.